Integrated BioPharma, Inc.
- Jurisdiction
United States - ISIN
US45811V1052 (INBP )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. Read full profile
Stock price
Fundamentals
- Net revenue
€46.63M - Gross margin
10.2% - EBIT
€1.73M - EBIT margin
3.7% - Net income
€693.26K - Net margin
1.5%
Statement period: - (published )
Dividends
- Last dividend amount
-
$0.50 - Ex date
-